Biopsy diagnosis of prostate cancer in patients with suspected prostate cancer undergoing their first biopsy: comparison of target biopsy alone vs target biopsy in addition to standard biopsy

Not Applicable

Completed

• Conditions: Prostate cancer; Cancer; Malignant neoplasm of prostate

• Registration Number: ISRCTN60263108
• Lead Sponsor: Ospedale San Luigi Gonzaga

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36626117/ primary results (added 11/01/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-10-15
• Study Start: 2022-03-09
• Last Update Posted: 23 January 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 384

Inclusion Criteria

1. Age <75 years
2. Negative history of previous prostate biopsies
3. Suspected serum prostate-specific antigen (PSA) values <15 ng/ml
4. Negative rectal examination (DRE)
5. Positive multiparametric magnetic resonance imaging

Exclusion Criteria

Contraindications to prostate biopsy (e.g., inability to discontinue anticoagulant therapy)

Study & Design

• Study Type: Interventional
• Study Design: Not specified